Arsenic trioxide, retinoic acid and Ara-c regulated the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen/tissue plasminogen activator

Thrombosis Research

Volumn 106, Issue 1, 2002, Pages 63-70

  Zhang, Xiaohui ^a   Zhou, Huarong ^b   Wang, Jun ^c   Yang, Linhua ^c   Hu, Yu ^a   Shen, Guanxin ^b   Guo, Peixue ^d   Qiao, Zhenhua ^c   Song, Shanjun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c SHANXI MEDICAL UNIVERSITY   (China)

^d Purdue University   (United States)

Author keywords

Annexin II; APL; Arsenic trioxide; Bleeding; Plasminogen; Retinoic acid

Indexed keywords

ARSENIC TRIOXIDE; CYTARABINE; FIBRINOGEN; LIPOCORTIN 2; MESSENGER RNA; PLASMIN; RETINOIC ACID; TISSUE PLASMINOGEN ACTIVATOR; ANTINEOPLASTIC AGENT; ARAC PROTEIN; BACTERIAL PROTEIN; ORGANOARSENIC DERIVATIVE; OXIDE; PLASMINOGEN ACTIVATOR; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; ANNEXIN A2; ANTINEOPLASTIC AGENTS; ARAC TRANSCRIPTION FACTOR; ARSENICALS; BACTERIAL PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HEMORRHAGE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; OXIDES; PLASMIN; PLASMINOGEN ACTIVATORS; REPRESSOR PROTEINS; RNA, MESSENGER; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTORS; TRANSFECTION; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0036544677     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00075-0     Document Type: Article

References (32)

1. Annexin II and bleeding in acute promyelocytic leukemia
2. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin
3. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic for tissue-type plasminogen activator
4. 60v-src and of epidermal growth factor receptor/kinase
5. α fusion protein inhibits differentiation and promotes survival of myeloid precursor cells
6. The impact of all-trans retinoic acid on the coagulopathy of acute promyelocytic leukemia
7. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia
8. Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukemia
9. Platelet and fibrinogen survival in acute promyelocytic leukemia
10. Coagulation disorders associated with acute promyelocytic leukemia: Corrective effect of all-trans retinoic acid treatment
11. Construction of recombinant adenoviral vector of annexin II
12. Modulation of poly (ADP-ribose) polymerase during neutrophilic and monocytic differentiation of promyelocytic (NB4) and myelocytic (HL-60) leukemia cells
13. Culture of human endothelial cells derived from umbilical cord veins. Identification and immunological criteria
14. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA): II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation
15. An endothelial cell receptor for plasminogen/tissue plasminogen activator: I. Identity with annexin II
16. Arsenic-induced PML targeting on to nuclear bodies: Implications for the treatment of acute promyelocytic leukemia
17. Annexin II and regulation of cell surface fibrinolysis
18. Deciphering the pathogenesis of coagulation dysfunction in leukemia
19. The plasminogen system and cell surface: Evidence for plasminogen and urokinase receptors on the same cell types
20. The molecular basis of fibrinolysis
21. In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): Effect of all-trans retinoic acid (ATRA) therapy
22. The impact of all-trans retinoic acid on the coagulopathy of acute promyelocytic leukemia
23. Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents
24. Annexin II: A novel mediator of cell surface plasmin generation
25. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and alteration of PML-RARα/PML protein localization
26. A PML/RARα transgene initiates murine acute promyelocytic leukemia
27. Successful treatment with tranexamic acid for severe bleeding in acute promyelocytic leukemia
28. Surface annexin II on placental membranes of the fetomaternal interface
29. An endothelial cell-surface form of annexin II binds human cytomegalovirus
30. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid
31. Expression of annexins on the surface of non-metastatic human and rodent tumor cells
32. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis